Literature DB >> 1923516

Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cells.

W Deppert1, M Kurth, M Graessmann, A Graessmann, U Knippschild.   

Abstract

The Rev2 cell line is a cellular revertant of the SV40 wild-type transformed rat cell line SV-52 [Bauer, M., Guhl, E., Graessmann, M. & Graessmann, A. (1987). J. Virol., 61, 1821-1827]. To characterize the level of cellular interference with the SV40 large T antigen (large T)-induced transformation pathway in Rev2 cells, we analysed the biological and biochemical properties of large T expressed in Rev2 cells. We found that Rev2 cells encoded an authentic wild-type large T, with regard to its sequence and its transforming functions. No differences were found in the metabolic stability of large T, or in complex formation with the cellular p53 protein, or in p53 metabolic stabilization. In contrast to SV-52 cells, Rev2 cells showed no association of large T with the chromatin fraction of isolated nuclei. This difference correlated with a reduced affinity of the Rev2 large T to SV40 DNA in vitro. The T proteins from both cell lines were phosphorylated at the same multiple sites. However, in Rev2 cells the phosphorylation of large T at specific serine -residues was significantly reduced. Thus the revertant phenotype of Rev2 cells may be due to an altered phosphorylation state of its large T protein, leading to altered nuclear localization and reduced transforming activity. The alterations of Rev2 large T properties and phosphorylation were very similar to the changes observed with mutant large T in FR(tsA58)A cells, an SV40 tsA58 N-type transformant, when the cells had reverted to the normal phenotype at the non-permissive growth temperature. Thus altered phosphorylation might provide a common structural basis for the biological inactivation of the large T proteins in these cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923516

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.

Authors:  W Henning; G Rohaly; T Kolzau; U Knippschild; H Maacke; W Deppert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Analysis of simian virus 40 small t antigen-induced progression of rat F111 cells minimally transformed by large T antigen.

Authors:  J Zerrahn; W Deppert
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

5.  The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300.

Authors:  M L Avantaggiati; M Carbone; A Graessmann; Y Nakatani; B Howard; A S Levine
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

6.  The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor.

Authors:  P Porcu; A Ferber; Z Pietrzkowski; C T Roberts; M Adamo; D LeRoith; R Baserga
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

7.  A truncated T antigen expressed from an alternatively spliced BK virus early mRNA.

Authors:  Johanna R Abend; Amy E Joseph; Dweepanita Das; Deniz B Campbell-Cecen; Michael J Imperiale
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

8.  Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells.

Authors:  T Patschinsky; U Knippschild; W Deppert
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.

Authors:  C Sell; M Rubini; R Rubin; J P Liu; A Efstratiadis; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA.

Authors:  J Zerrahn; U Knippschild; T Winkler; W Deppert
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.